摘要
目的探究视网膜静脉阻塞黄斑水肿患者眼内注射康柏西普的疗效。方法对2014年1月至2015年1月期间收治的152例视网膜静脉阻塞黄斑水肿患者的临床治疗进行统计分析。结果术后12、24周观察组患者的BCVA测定值高于对照组,术后12、24周观察组CMT测定值低于对照组,观察组(5.25%)并发症总发生率显著低于对照组(11.82%),差异具有统计学意义(P<0.05)。结论给予视网膜静脉阻塞黄斑水肿患者激光光凝联合玻璃体腔内注射康柏西普治疗较单纯使用激光光凝治疗能够有1效缓解临床症状,提高眼视力,且安全性较佳。
Objective To explore the curative effect of intraocularly injected conbercept on macular ede- ma in retinal vein occlusion. Methods The clinical data of 152 cases of patients with macular edema in retinal vein obstruction in our hospital from January 2014 to January 2015 were statistically analyzed. Results The BCVA levels 12 and 24 weeks after treatment in the observation group were significantly higher than the control group, and the CMT levels 12 and 24 weeks after treatment in the observation group were significantly lower than the con- trol group. The total incidence rate of complications in the observation group was significantly lower than the control group （5.25% vs. 11.82%, P 〈 0.05）. Conclusion Laser photocoagulation combined with intravitreal injection with Conbercept is more effective than the use of laser photocoagulation alone in , relieving clinical symptoms, improve eyesight and has better safety for the patients with macular edema in retinal vein occlusion
出处
《实用医学杂志》
CAS
北大核心
2017年第23期3971-3974,共4页
The Journal of Practical Medicine
基金
广东省科技厅计划项目(编号:2016A02021212002)
广东省科技公益研究与能力建设项目(编号:2014B020212019)
广东省省级科技计划项目(援疆专项)(编号:2014A020209029)
关键词
玻璃体腔注射
康柏西普
视网膜静脉阻塞黄斑水肿
激光光凝
vitreous cavity injection
conbercept
macular edema in retinal vein occlusion
laser photocoagulation
